Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1924 1
1965 2
1966 2
1968 1
1969 1
1970 1
1971 3
1973 1
1974 3
1975 2
1977 4
1979 1
1980 2
1981 5
1982 4
1983 3
1984 2
1985 7
1986 7
1987 4
1988 11
1989 4
1990 3
1991 9
1992 8
1993 12
1994 5
1995 5
1996 12
1997 23
1998 15
1999 17
2000 5
2001 13
2002 15
2003 19
2004 30
2005 42
2006 43
2007 61
2008 42
2009 45
2010 66
2011 94
2012 108
2013 117
2014 154
2015 177
2016 156
2017 180
2018 222
2019 207
2020 336
2021 482
2022 532
2023 453
2024 166

Text availability

Article attribute

Article type

Publication date

Search Results

3,504 results

Results by year

Filters applied: . Clear all
Page 1
Long-Term Outcomes of Resynchronization-Defibrillation for Heart Failure.
Sapp JL, Sivakumaran S, Redpath CJ, Khan H, Parkash R, Exner DV, Healey JS, Thibault B, Sterns LD, Lam NHN, Manlucu J, Mokhtar A, Sumner G, McKinlay S, Kimber S, Mondesert B, Talajic M, Rouleau J, McCarron CE, Wells G, Tang ASL; RAFT Long-Term Study Team. Sapp JL, et al. Among authors: khan h. N Engl J Med. 2024 Jan 18;390(3):212-220. doi: 10.1056/NEJMoa2304542. N Engl J Med. 2024. PMID: 38231622 Clinical Trial.
Harlequin syndrome.
Sharma R, Khan H. Sharma R, et al. Among authors: khan h. Neurol Sci. 2023 Aug;44(8):2989-2990. doi: 10.1007/s10072-023-06849-y. Epub 2023 May 18. Neurol Sci. 2023. PMID: 37199876
The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study - 6 month results.
Khanani AM, Aziz AA, Khan H, Gupta A, Mojumder O, Saulebayeva A, Abbey AM, Almeida DRP, Avery RL, Banda HK, Barakat MR, Bhandari R, Chang EY, Haug SJ, London NJS, Mein L, Sheth VS, Wolfe JD, Singer MA, Danzig CJ. Khanani AM, et al. Among authors: khan h. Eye (Lond). 2023 Dec;37(17):3574-3581. doi: 10.1038/s41433-023-02553-5. Epub 2023 May 12. Eye (Lond). 2023. PMID: 37173428 Free PMC article.
Force-adjustable parallel-occlusion grasper.
Khan H, Coleman S, Cuschieri A. Khan H, et al. Int J Surg. 2024 Feb 1;110(2):750-757. doi: 10.1097/JS9.0000000000000911. Int J Surg. 2024. PMID: 37995091 Free PMC article.
Futility considerations in surgical ethics.
Udwadia FR, Zhu J, Khan HM, Das S. Udwadia FR, et al. Among authors: khan hm. Ann Med Surg (Lond). 2023 Jan 23;85(1):1-5. doi: 10.1097/MS9.0000000000000114. eCollection 2023 Jan. Ann Med Surg (Lond). 2023. PMID: 36742120 Free PMC article.
SMARCB1 regulates the hypoxic stress response in sickle cell trait.
Soeung M, Perelli L, Chen Z, Dondossola E, Ho IL, Carbone F, Zhang L, Khan H, Le CN, Zhu C, Peoples MD, Feng N, Jiang S, Zacharias NM, Minelli R, Shapiro DD, Deem AK, Gao S, Cheng EH, Lucchetti D, Walker CL, Carugo A, Giuliani V, Heffernan TP, Viale A, Tannir NM, Draetta GF, Msaouel P, Genovese G. Soeung M, et al. Among authors: khan h. Proc Natl Acad Sci U S A. 2023 May 23;120(21):e2209639120. doi: 10.1073/pnas.2209639120. Epub 2023 May 15. Proc Natl Acad Sci U S A. 2023. PMID: 37186844 Free PMC article.
Biomedical applications of engineered heparin-based materials.
Nazarzadeh Zare E, Khorsandi D, Zarepour A, Yilmaz H, Agarwal T, Hooshmand S, Mohammadinejad R, Ozdemir F, Sahin O, Adiguzel S, Khan H, Zarrabi A, Sharifi E, Kumar A, Mostafavi E, Kouchehbaghi NH, Mattoli V, Zhang F, Jucaud V, Najafabadi AH, Khademhosseini A. Nazarzadeh Zare E, et al. Among authors: khan h. Bioact Mater. 2023 Aug 10;31:87-118. doi: 10.1016/j.bioactmat.2023.08.002. eCollection 2024 Jan. Bioact Mater. 2023. PMID: 37609108 Free PMC article. Review.
Interferon signaling promotes tolerance to chromosomal instability during metastatic evolution in renal cancer.
Perelli L, Carbone F, Zhang L, Huang JK, Le C, Khan H, Citron F, Del Poggetto E, Gutschner T, Tomihara H, Soeung M, Minelli R, Srinivasan S, Peoples M, Lam TNA, Lundgren S, Xia R, Zhu C, Mohamed AMT, Zhang J, Sircar K, Sgambato A, Gao J, Jonasch E, Draetta GF, Futreal A, Bakouny Z, Van Allen EM, Choueiri T, Signoretti S, Msaouel P, Litchfield K, Turajlic S, Wang L, Chen YB, Di Natale RG, Hakimi AA, Giuliani V, Heffernan TP, Viale A, Bristow CA, Tannir NM, Carugo A, Genovese G. Perelli L, et al. Among authors: khan h. Nat Cancer. 2023 Jul;4(7):984-1000. doi: 10.1038/s43018-023-00584-1. Epub 2023 Jun 26. Nat Cancer. 2023. PMID: 37365326 Free PMC article.
Understanding the Therapeutic Approaches for Neuroprotection.
Payal N, Sharma L, Sharma A, Hobanii YH, Hakami MA, Ali N, Rashid S, Sachdeva M, Gulati M, Yadav S, Chigurupati S, Singh A, Khan H, Behl T. Payal N, et al. Among authors: khan h. Curr Pharm Des. 2023;29(42):3368-3384. doi: 10.2174/0113816128275761231103102125. Curr Pharm Des. 2023. PMID: 38151849 Review.
3,504 results